The Global Pharmaceutical Industry
Download The Global Pharmaceutical Industry full books in PDF, epub, and Kindle. Read online free The Global Pharmaceutical Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Daniel Hoffman |
Publisher |
: Routledge |
Total Pages |
: 95 |
Release |
: 2020-07-06 |
ISBN-10 |
: 9781000166712 |
ISBN-13 |
: 1000166716 |
Rating |
: 4/5 (12 Downloads) |
Synopsis The Global Pharmaceutical Industry by : Daniel Hoffman
The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-of-living increases during the past two decades and have reached a point where 30% of Americans must choose between filling a prescription, paying for housing, and buying food. This has brought about public pressure on governments around the world to control drug prices, yet the world’s twenty largest pharma companies realized 80% of their growth as a result of exorbitant price hikes. Pharma currently enjoys its extraordinary profitability by exploiting the world’s most vulnerable populations. Yet even their ability to increase prices in the face of falling demand does not satisfy their profit demands. The breadth and depth of pharma’s marketing transgressions exceed those of any other industry and have now reached a point where authorities around the world have found it necessary to take legal action against its violations. Drastic change is needed if the pharmaceutical industry can equitably advance the health of the world’s population and regain public esteem. This book illustrates the range and extent of pharma’s violations and addresses the actions that should be implemented in order to make the drug industry a more constructive, less venal part of contemporary society. It will be of interest to researchers, academics, practitioners, and students with an interest in the pharmaceutical industry, healthcare management, regulation, and bioethics.
Author |
: Nozari, Hamed |
Publisher |
: IGI Global |
Total Pages |
: 399 |
Release |
: 2018-11-09 |
ISBN-10 |
: 9781522559221 |
ISBN-13 |
: 1522559221 |
Rating |
: 4/5 (21 Downloads) |
Synopsis Global Supply Chains in the Pharmaceutical Industry by : Nozari, Hamed
In a rapidly growing global economy, where there is a constant emergence of new business models and dynamic changes to the business ecosystem, there is a need for the integration of traditional, new, and hybrid concepts in the complex structure of supply chain management. Within the fast-paced pharmaceutical industry, product strategy, life cycles, and distribution must maintain the highest level of agility. Therefore, organizations need strong supply chain capabilities to profitably compete in the marketplace. Global Supply Chains in the Pharmaceutical Industry provides innovative insights into the efforts needed to build and maintain a strong supply chain network in order to achieve efficient fulfillment of demand, drive outstanding customer value, enhance organizational responsiveness, and build network resiliency. This publication is designed for supply chain managers, policymakers, researchers, academicians, and students, and covers topics centered on economic cycles, sustainable development, and new forces in the global economy.
Author |
: Adriana Petryna |
Publisher |
: Duke University Press |
Total Pages |
: 314 |
Release |
: 2006-03-15 |
ISBN-10 |
: 082233741X |
ISBN-13 |
: 9780822337416 |
Rating |
: 4/5 (1X Downloads) |
Synopsis Global Pharmaceuticals by : Adriana Petryna
DIVAnthropological study of the globalization of pharmaceuticals and its effects on local cultures, health, and economics./div
Author |
: Axel Jörn |
Publisher |
: Anchor Academic Publishing |
Total Pages |
: 29 |
Release |
: 2016-02-05 |
ISBN-10 |
: 9783960675068 |
ISBN-13 |
: 3960675062 |
Rating |
: 4/5 (68 Downloads) |
Synopsis Pfizer and the Challenges of the Global Pharmaceutical Industry by : Axel Jörn
This Case Study defines the global pharmaceutical industry and its „boundaries“, analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters’ Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer’s new strategy and examines what Pfizer did in the recent years to maintain their profitability.
Author |
: Frederick M. Abbott |
Publisher |
: Edward Elgar Publishing |
Total Pages |
: 319 |
Release |
: 2009-01-01 |
ISBN-10 |
: 9781849801843 |
ISBN-13 |
: 1849801843 |
Rating |
: 4/5 (43 Downloads) |
Synopsis Global Pharmaceutical Policy by : Frederick M. Abbott
There is a strong argument that people throughout the world have a right to receive the medicines they need in an appropriate, affordable, and timely way. Global Pharmaceutical Policy describes the laws, policies, and customs relating to the development and provision of medicines, identifies their strengths and weakness, and then proposes global solutions for getting things better. Here is a masterpiece written in a clear and elegant style. Together, Dukes and Abbott have experience and insight that are unrivalled. Joe Collier, Emeritus Professor of Medicines Policy, St George s, University of London, UK Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world s poor see little effort to address diseases prevalent in less affluent societies, while the world s wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade.
Author |
: Billy Kenber |
Publisher |
: Canongate Books |
Total Pages |
: 553 |
Release |
: 2021-10-07 |
ISBN-10 |
: 9781838850272 |
ISBN-13 |
: 1838850279 |
Rating |
: 4/5 (72 Downloads) |
Synopsis Sick Money by : Billy Kenber
THE PHARMACEUTICAL INDUSTRY IS BROKEN From the American hedge fund manager who drastically hiked the price of an AIDS pill to the children’s cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and improve patient care has been distorted to maximise profits. In Sick Money, the investigative journalist who exposed a billion-pound British price-hiking scandal goes inside the global battle over high drug prices. From secret deals to patients forced to turn to the black market, Billy Kenber reveals how medicines have become nothing more than financial assets. He offers a diagnosis of an industry in crisis - and a prescription for how it could be fixed.
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 225 |
Release |
: 1991-02-01 |
ISBN-10 |
: 9780309044912 |
ISBN-13 |
: 030904491X |
Rating |
: 4/5 (12 Downloads) |
Synopsis The Changing Economics of Medical Technology by : Institute of Medicine
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Author |
: Hans Löfgren |
Publisher |
: Taylor & Francis |
Total Pages |
: 370 |
Release |
: 2017-07-06 |
ISBN-10 |
: 9781351470605 |
ISBN-13 |
: 1351470604 |
Rating |
: 4/5 (05 Downloads) |
Synopsis The Politics of the Pharmaceutical Industry and Access to Medicines by : Hans Löfgren
Some papers presented at a conference held at Hyderabad in September 2010.
Author |
: Congressional Budget Office |
Publisher |
: Lulu.com |
Total Pages |
: 65 |
Release |
: 2013-06-09 |
ISBN-10 |
: 9781304121448 |
ISBN-13 |
: 1304121445 |
Rating |
: 4/5 (48 Downloads) |
Synopsis Research and Development in the Pharmaceutical Industry (A CBO Study) by : Congressional Budget Office
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...
Author |
: Lea Prevel Katsanis |
Publisher |
: Routledge |
Total Pages |
: 193 |
Release |
: 2015-07-16 |
ISBN-10 |
: 9781136313301 |
ISBN-13 |
: 1136313303 |
Rating |
: 4/5 (01 Downloads) |
Synopsis Global Issues in Pharmaceutical Marketing by : Lea Prevel Katsanis
Global Issues in Pharmaceutical Marketing presents a balanced, research-based perspective combined with a practical outlook on the current issues faced by the ethical, biotech, and generic segments of the pharmaceutical industry. It integrates an analytical approach with a global view to examine such issues as market access, digital marketing, emerging markets, branding, and more. The book covers not only the North American and Western European markets, but focuses on non-Western markets, such as Latin America and Asia. Each chapter is written as an individual essay about a given issue, and where relevant, original cases are provided to illustrate how these issues are currently managed by the global industry. This book offers a thoughtful and thorough description of the industry’s current situation and integrates the latest scholarly and industry research from different disciplines in one place for convenient reference. It may be used in the following ways: To stimulate class discussions and inspire new streams of research for academics and graduate students; To introduce the industry to those interested in a career, to orient new industry hires, or to provide experienced practitioners with current research that will enhance their knowledge; To provide an understanding of the industry for those in the healthcare sector, such as physicians, pharmacists, as well as medical and pharmacy students; and To present recent and relevant research for those in government, public or private payers, and public policy environments to facilitate their decision making. This book will prove to be a useful resource and an important source of information for academics and their students, professionals, and policymakers around the world.